Peripartal cardiomyopathy: literature review and clinical case description

The cardiovascular system during pregnancy undergoes a number of compensatory and adaptive changes, such as an increase in heart rate, cardiac output and total peripheral resistance, which causes an increase in the load on the myocardium. Peripartum cardiomyopathy is a serious polyetiological complication of pregnancy and the postpartum period, as well as an important cause of disability and mortality for both mother and fetus. The non-specificity of complaints and the paucity of clinical symptoms in the early stages of the disease lead to delayed diagnosis and significantly increase the frequency of unfavorable outcomes. In the article we present our own clinical observation of the acute development of severe peripartum cardiomyopathy in a multipregnant woman at 36 weeks of gestation, complicated by cardiogenic shock and antenatal fetal death.

1. Bauersachs J, Konig T, van der Meer P, Petrie M.C., Hilfiker-Kleiner D., Mbakwem A. et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–843. https://doi.org/10.1002/ejhf.1493

2. Bala R., Mehta S., Roy V. C., Kaur G., de Marvao A. Peripartum cardiomyopathy: A review. Revista Portuguesa de Cardiologia. 2023;42:917-924. https://doi.org/10.1016/j.repc.2023.01.029

3. Davis M. B., Arany Z., McNamara D. M., Goland S., Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. Journal of the American College of Cardiology. 2020; 75(2):207-221. https://doi.org/10.1016/j.jacc.2019.11.014

4. Rudaeva E.V., Khmeleva I.A., Moses K.B., Moses V.G., Zakharov I.S., Elgina S.I., et al. Peripartum cardiomyopathy: epidemiology, pathogenesis, obstetric tactics. Complex problems of cardiovascular diseases. 2021;10(1):73-82. (In Russ). https://doi.org/10.17802/2306-1278-2021-10-1-73-82

5. Mielniczuk L.M, Williams K., Davis D.R., et al. Frequency of peripartum cardiomyopathy. The American Journal of Cardiology, 2006;97:1765–8. https://doi.org/10.1016/j.amjcard.2006.01.039

6. Iorgoveanu C., Zaghloul A., Ashwath M. Peripartum cardiomyopathy: a review. Heart failure reviews. 2021;26(6):1287-1296. https://doi.org/10.1007/s10741-020-10061-x

7. Bello N., Rendon IS., Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2013;62:1715–23. https://doi.org/10.1016/j.jacc.2013.08.717

8. Kolte D., Khera S., Aronow WS., et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. Journal of the American Heart Association. 2014;3:e001056. https://doi.org/10.1161/JAHA.114.001056

9. Haghikia A., Podewski E., Libhaber E., et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic research in cardiology. 2013;108:366. https://doi.org/10.1007/s00395-013-0366-9

10. Ware JS., Li J., Mazaika E., et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. New England Journal of Medicine. 2016;374:233–41. https://doi.org/10.1056/NEJMoa1505517

11. Al-Mubarak A.A., van der Meer P., Bomer N. Selenium, seleno-proteins, and heart failure: current knowledge and futureperspective. Current heart failure reports. 2021;18:122-131. https://doi.org/10.1007/s11897-021-00511-4

12. Sanghavi M., Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003-8. https://doi.org/10.1161/circulationaha.114.009029

13. Sliwa K., Skudicky D., Candy G., Bergemann A., Hopley M., Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. European Journal of Heart Failure. 2002; 4(3):305–309. https://doi.org/10.1016/S1388-9842(02)00008-9

14. Liu J., Wang Y., Chen M., et al. The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascularreceptors. PLoS One. 2014;9:1-8. https://doi.org/10.1371/journal.pone.0086041

15. Kara RJ., Bolli P., Karakikes I. et al. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circulation research. 2012; 110(1):82–93. https://doi.org/10.1161/circresaha.111.249037

16. Bültmann B.D, Klingel K., Näbauer M., Wallwiener D., Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. American Journal of Obstetrics and Gynecology. 2005; 193(2):363–365. https://doi.org/10.1016/j.ajog.2005.01.022

17. Lamparter S., Pankuweit S., Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. International journal of cardiology. 2007; 118(1):14–20. https://doi.org/10.1016/j.ijcard.2006.04.090

18. Sliwa K., Petrie M.C., van der Meer P., et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. European heart journal. 2020; 41(39):3787–3797. https://doi.org/10.1093/eurheartj/ehaa940

19. Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J., Blomstrom-Lundqvist C., Cifkova R. et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. European heart journal. 2018;39:3165–3241. https://doi.org/10.1093/eurheartj/ehy340

20. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P. et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121:1465–1473. https://doi.org/10.1161/circulationaha.109.901496

21. Tsoi IA, Abdullaev TA, Khudoyberganov OK, Mirzarakhimova ST. Five-year prognosis of life in patients with peripartum cardiomyopathy. Russian Cardiology Bulletin. 2022;17(3):58–62. (In Russ). https://doi.org/10.17116/Cardiobulletin20221703158

22. Jawad K., Koziarz A., Dieterlen M.T., et al. Long-term follow-up ofmechanical circulatory support in peripartum cardiomyopathy(PPCM) refractory to medical management: a multicenter study. Life. 2022;12:1-7. https://doi.org/10.3390/life12010087